ArticleMethods in molecular biology (Clifton, N.J.)2025
In Vitro and In Vivo Models Studying Haemophilus influenzae.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Investigating the infiltration of Haemophilus influenzae into the central nervous system (CNS) involves exploring cellular migration across the blood-brain barrier (BBB). This study delves into established methodologies, encompassing both in vitro and in vivo approaches, to elucidate how H. influenzae disrupts the BBB, ultimately causing CNS infection. Moreover, the experiment sheds light on the impact of tumor necrosis factor (TNF)-α on zyxin levels. In the presence of cytokine TNF-α, human brain microvascular endothelial cells (HBMEC) exhibited a significant reduction in zyxin expression, accompanied by an increase in [specific effect]. Correspondingly, the introduction of H. influenzae as a cell-bound organism (CBO) in mice resulted in dire consequences for zyxin-deficient mice, emphasizing the critical role of zyxin in this context.
Indexed as
Identifiers
40622527What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.